With the development of globalization and digital transformation

market competition is becoming more and more fierce. When the scale of enterprises expands to a certain extent

there will be a variety of problems

such as financial fraud. Pharmaceutical manufacturing industry has an important impact on the life and health of the public

and whether its internal control system is sound directly affects the development and stability of China's economy. Through the analysis of the delisting incident of Guangdong taiantang Pharmaceutical Co.

Ltd.

this paper finds that there are major defects in its internal control

and there are corresponding problems in the disclosure of internal control information

and puts forward suggestions for improvement. It is hoped that the public will attach great importance to the disclosure of internal control information of enterprises in China

and provide some reference and reference.